Delivery Order SPE2DB24D2100-SPE2DB25FBGGC
- Not listed
- The Defense Logistics Agency awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp for Talzenna 0.5 mg softgels (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for Talzenna 0.35 mg softgel capsules (30-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $30,008.88, is for the supply of a specialty medication, Talzenna 1 mg capsule, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This award is issued under a larger indefinite delivery contract (IDC) between...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.25 mg softgel capsules of the drug Talzenna, with a ceiling value of $11,135.25 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,424.08 firm fixed-price delivery order is for the supply of Talzenna 0.5 mg capsules. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- The Defense Logistics Agency Troop Support Medical awarded a $20,081.70 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 4561935121 TALZENNA 0.25 MG CAPSULE 30S. The place of performance will be Conshohocken, Pennsylvania, with work scheduled to be completed by September 15, 2023 after starting on August 24, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement, distribution and...
- This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD7YN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,848.16 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Talzenna 0.5 mg capsules. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this single-award...
- The Defense Logistics Agency awarded a $10,040.85 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562031278 TALZENNA 0.25 MG CAPSULE 30S. The prime contractor will deliver the specified pharmaceutical product from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by September 25, 2023 in support of the agency's medical supply needs. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency awarded a $10,002.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561636940 TALZENNA 0.5 MG CAPSULE 30S. The prime contractor, Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 18, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TALZENNA 0.25 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $10,040.85, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to the DLA Troop Support Medical facility located in Conshohocken, Pennsylvania. This award...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGGCDelivery Order
The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that supports global pharmaceutical procurement for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio includes specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. This Talzenna delivery order represents a routine transaction within the company's comprehensive pharmaceutical supply relationship with DLA, demonstrating its ongoing capability to fulfill federal military healthcare medication requirements through firm fixed-price mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/9/25 |